attachment

Stool microscopy it doesn’t looks like parasite

Reading Document
Medical Text Search

stool microscopy non-parasitic findings artifacts plant cells food debris

Medical Image Search

stool microscopy artifacts plant cells pollen food particles

GradeResponse
GradeResponse
Looking at the image carefully, here is what can be identified:

Stool Microscopy — Image Analysis

What You're Seeing

The orange/red-orange elongated and irregularly shaped fragments scattered throughout the field are almost certainly plant cell fragments or dietary fiber remnants — not parasites. Specifically, they resemble:
  • Plant fiber/cellulose fragments from undigested vegetable or grain matter
  • Pollen grains (some have the characteristic irregular, lobulated outline)
  • Possibly starch granules partially digested

Key Distinguishing Features (Why These Are NOT Parasites)

FeatureWhat's SeenParasite Expected
ShapeIrregular, angular, plant-cell-likeRounded/oval with defined wall
Internal structureNo nucleus, no organelles visibleNuclei, cysts have internal features
ArrangementRandom scatterOften clustered or motile
ColorBright orange-red (likely iodine-stained or autofluorescent)Brown/gold with distinct wall
Size variationHighly variableMore uniform per species

Common Non-Parasitic Findings in Stool Microscopy

  • Plant cells / vegetable fibers — very common, often mistaken for parasite fragments
  • Pollen — seasonal, rounded/spiky appearance
  • Muscle fibers (from meat) — cylindrical with striations
  • Fat globules — round, refractile
  • Starch granules — oval, stain blue-black with iodine
  • Yeast cells — small, budding oval forms (Candida spp. — not always pathogenic)
  • Epithelial cells — large, flat polygonal cells

Recommendation

Your assessment is correct — no parasites are identified in this field. The structures present are consistent with dietary debris/plant material.
For a complete stool O&P (ova and parasites) exam, multiple fields should be examined using both direct wet mount and concentrated preparations (formalin-ethyl acetate), and iodine stain for cysts. If clinical suspicion remains, consider:
  • Repeat stool exam × 3 samples on different days
  • Specific antigen tests (e.g., Giardia/Cryptosporidium EIA)
  • PCR-based stool pathogen panels for higher sensitivity

How to make 0.8 % suspension ??

Preparing a 0.8% Fecal Suspension for Stool Microscopy

A 0.8% suspension refers to an 0.85% normal saline (physiological saline) wet mount preparation — the standard diluent for direct stool microscopy.

Preparing 0.85% Normal Saline Stock Solution

If making from scratch:
ComponentAmount
NaCl (table/lab salt)0.85 g
Distilled water100 mL
Dissolve and mix well. This is your diluent.

Making the Stool Suspension

Standard direct wet mount method:
  1. Place 1–2 drops of 0.85% saline on a clean glass slide
  2. Pick a small amount of stool (~2 mg, approximately the size of a match head) using an applicator stick
  3. Emulsify thoroughly into the saline drops — mix well until evenly suspended
  4. The suspension should be thin enough to read newsprint through — if too thick, add more saline
  5. Apply a coverslip (22×22 mm)
  6. Examine under 10× then 40× objective

Formalin-Based Suspension (for concentration)

For preserved/concentrated preparations:
ComponentRatio
Stool1 part (~1 g)
10% formalin or SAF fixative9–10 parts (9–10 mL)
This gives approximately a 10% fecal suspension in fixative, which is then concentrated by formalin-ethyl acetate sedimentation.

Key Tips

  • Always prepare two slides — one with saline (motility/trophozoites), one with Lugol's iodine (cysts/nuclei detail)
  • Use fresh stool within 30 minutes for trophozoite detection
  • The suspension should look faintly turbid/cloudy, not opaque

0.8% of Pooled RBC how to make ???

Preparing 0.8% Pooled RBC Suspension

This is used in serological tests (e.g., Widal test, TPHA, hemagglutination assays) as the indicator cell suspension.

What You Need

ItemPurpose
Blood samples (2–3 donors or pooled)Source of RBCs
0.85% Normal Saline (physiological saline)Washing & suspension medium
CentrifugeCell separation
Test tubes, pipettesLabware

Step-by-Step Protocol

Step 1 — Collect & Pool Blood

  • Collect blood from 2–3 donors into EDTA tubes (anticoagulated)
  • Pool equal volumes together in a clean tube

Step 2 — Wash the RBCs (×3)

  1. Add 5–10 mL saline to pooled blood
  2. Centrifuge at 1000–1500 rpm for 5 minutes
  3. Discard the supernatant + buffy coat (white cell layer) carefully
  4. Repeat washing 3 times until supernatant is clear (no hemolysis)
After 3 washes you have a packed RBC pellet

Step 3 — Make the 0.8% Suspension

ComponentVolume
Packed RBC pellet0.8 mL
0.85% Normal Saline99.2 mL
Total100 mL
Simply put: 0.8 mL packed RBCs + 99.2 mL saline = 0.8% RBC suspension
For smaller volumes (e.g., 10 mL total):
Packed RBCsSaline
0.08 mL (80 µL)9.92 mL

Quick Formula

$$\text{Packed RBC volume} = \frac{0.8}{100} \times \text{Total volume desired}$$

Quality Check

  • The suspension should appear uniformly turbid/pink
  • No clumping or hemolysis (clear supernatant after settling)
  • Use fresh preparation — ideally same day or store at 2–8°C for up to 1 week

Common Uses of 0.8% RBC Suspension

TestPurpose
Widal testSalmonella antibody detection
TPHATreponema pallidum hemagglutination
IHA (Indirect Hemagglutination)Parasitic/bacterial serology
ABO/Rh blood groupingCrossmatching
Coombs testHemolytic anemia workup

0.8 mL in microlitre and 99.2 mL too

Unit Conversions

Simple Rule

1 mL = 1000 µL

0.8 mL → Microlitres

$$0.8 \times 1000 = \textbf{800 µL}$$

99.2 mL → Microlitres

$$99.2 \times 1000 = \textbf{99,200 µL}$$

Summary Table

ComponentmLµL
Packed RBCs0.8 mL800 µL
0.85% Saline99.2 mL99,200 µL
Total100 mL100,000 µL

For Smaller Volumes (Practical Bench Use)

If making only 10 mL total:
ComponentmLµL
Packed RBCs0.08 mL80 µL
0.85% Saline9.92 mL9,920 µL
Total10 mL10,000 µL
For bench work, use a micropipette for the RBC volume (80 µL) and a measuring cylinder for the saline.

It is much ??

Yes, 100 mL is a large volume for routine bench work.

More Practical Small-Scale Volumes

Total VolumePacked RBCsSaline
100 mL800 µL99.2 mL
10 mL80 µL9.92 mL
5 mL40 µL4.96 mL
1 mL8 µL992 µL

Most Common Bench Practice

For daily routine use, labs typically prepare:
5–10 mL total — enough for a full day's batch of tests
So the most practical preparation is:
ComponentAmount
Packed RBCs80 µL
0.85% Saline9.92 mL (~10 mL)
Total10 mL
  • Use a micropipette for the 80 µL RBCs
  • Use a measuring cylinder or graduated tube for saline
  • Gives enough suspension for ~100–200 test drops depending on the assay

Tip: Only prepare what you need for the day — fresh suspension gives better, more reliable results.

Can a gravida three with two prior live children with RH positive blood group . Mother is Rh negative. Can her indirect Coombs test can come negative ??

Medical Text Search

indirect Coombs test negative Rh negative mother Rh positive fetus alloimmunization

Medical Text Search

Rh isoimmunization anti-D antibody formation prevention RhoGAM

GradeResponse
GradeResponse

Can ICT Be Negative in This Scenario?

Short Answer

Yes — a negative ICT is possible and actually occurs in several common situations.

Understanding the Scenario

FactorDetail
Gravida3
Para2 (both live, both Rh positive)
MotherRh negative
Current fetusRh positive
ICT resultNegative

Reasons ICT Can Be Negative

1. Anti-D Prophylaxis (RhoGAM) Given Properly

  • If the mother received anti-D immunoglobulin (RhoGAM):
    • At 28 weeks in previous pregnancies
    • After each delivery of Rh+ baby
    • After any sensitizing events (miscarriage, amniocentesis, trauma)
  • The administered anti-D is passively acquired and clears within 12 weeks
  • No active alloimmunization occurs → ICT stays negative
  • This is the most common reason for a negative ICT

2. Insufficient Fetomaternal Hemorrhage (FMH)

  • In previous pregnancies, the volume of fetal blood entering maternal circulation may have been too small to trigger an immune response
  • Sensitization requires a threshold volume of Rh+ RBCs
  • Small FMH → no antibody formation → ICT negative

3. Immune Tolerance

  • Some Rh-negative women simply fail to mount an antibody response despite exposure
  • Approximately 30% of Rh-negative mothers never become sensitized even without prophylaxis
  • Genetic factors influence immune responsiveness

4. Early Gestational Age at Testing

  • Anti-D antibodies may be below detectable threshold early in pregnancy
  • ICT may turn positive later — repeat testing is essential

5. Previous Children Were Actually Rh Negative

  • If prior children were Rh negative (depends on father's genotype), no sensitizing exposure occurred
  • Father could be heterozygous (Dd) — 50% chance each child is Rh negative

Clinical Implications — What To Do

ActionTiming
Repeat ICTEvery 4 weeks if negative (28–36 weeks)
Anti-D prophylaxisGive at 28 weeks regardless of ICT result
Anti-D after deliveryIf baby confirmed Rh positive, give within 72 hours
Check father's Rh genotypeHelps predict fetal Rh status
Kleihauer-Betke testIf large FMH suspected — quantifies fetal cells in maternal blood

Key Takeaway

A negative ICT does not mean the mother is safe to ignore — it means she has not yet formed antibodies. She remains at risk with every Rh+ pregnancy. Prophylaxis must continue.
The goal is to keep the ICT negative through timely RhoGAM administration — a negative result in a protected mother is the desired outcome, not a paradox.

If it came weak positive then ??

Medical Text Search

weak positive indirect Coombs test Rh negative mother management titration

Medical Text Search

anti-D antibody titer critical level fetal monitoring hemolytic disease newborn

GradeResponse
GradeResponse

Weak Positive ICT — What It Means & What To Do


First — Distinguish the Cause

CauseInterpretation
Recent RhoGAM injection (within 12 weeks)Passive anti-D — not dangerous, expected finding
True alloimmunization (active immune response)Dangerous — requires close monitoring
This distinction is the most critical first step

If Passive (Post-RhoGAM)

  • Weak positive is expected and reassuring
  • Titer usually ≤1:4
  • Will disappear within 12 weeks of injection
  • No fetal risk
  • Continue routine antenatal care

If True Alloimmunization (Active Anti-D)

Step 1 — Perform Antibody Titration Immediately

Titer LevelInterpretationAction
≤ 1:4Weak, low riskRepeat every 4 weeks
1:8 – 1:16BorderlineClose monitoring, repeat every 2 weeks
≥ 1:16 – 1:32Critical levelRefer to fetal medicine specialist urgently
> 1:32High riskFetal anemia likely — invasive monitoring
Critical titer = 1:16 (most centers) — threshold above which fetal hydrops risk rises significantly

Step 2 — Fetal Surveillance

Once critical titer is reached or rising:
InvestigationPurpose
Middle Cerebral Artery Doppler (MCA-PSV)Non-invasive assessment of fetal anemia — first line
MCA-PSV > 1.5 MoMIndicates moderate-severe fetal anemia
Fetal cordocentesisConfirms fetal Hb directly — done if MCA abnormal
Intrauterine transfusion (IUT)Treatment if fetal Hb critically low
Obstetric ultrasoundLook for hydrops (ascites, pleural effusion, skin edema)

Step 3 — Serial Antibody Monitoring Schedule

Per guidelines (Investigation and Management of Red Cell Antibodies in Pregnancy, p.11):
  • Every 4 weeks up to 28 weeks gestation
  • Every 2 weeks from 28 weeks until delivery
  • Refer to fetal medicine if titer reaches critical level or is rising significantly

Signs of Fetal Hemolytic Disease to Watch For on USS

  • Fetal hydrops (skin edema, ascites, pleural/pericardial effusion)
  • Placentomegaly
  • Polyhydramnios
  • Enlarged fetal liver/spleen (hepatosplenomegaly)

Delivery Planning

SituationPlan
Titer low, stable, no fetal compromiseDeliver at 37–38 weeks
Rising titer, MCA-PSV borderlineDeliver at 34–36 weeks with steroid cover
Fetal hydrops / severe anemiaImmediate IUT + deliver as soon as viable

After Delivery

  • Do NOT give RhoGAM if mother is truly alloimmunized — it has no benefit once sensitization has occurred
  • Newborn needs:
    • Direct Coombs Test (DCT)
    • Cord blood Hb + bilirubin
    • Monitor for neonatal jaundice / hemolytic disease of the newborn (HDN)
    • Possible phototherapy or exchange transfusion

Key Takeaway

A weak positive ICT in a G3P2 Rh-negative mother with Rh-positive children means early alloimmunization is likely underway. The priority is to titrate immediately, distinguish passive from active antibody, and begin serial fetal surveillance before the titer climbs to dangerous levels.

In term of gel card grading

Gel Card (Column Agglutination) Grading for ICT


Standard Gel Card Grading Scale

GradeAppearanceInterpretation
4+Single solid red band at top of gel columnStrong positive
3+Large agglutinates in upper half of columnModerate-strong positive
2+Agglutinates throughout columnModerate positive
1+Small agglutinates in lower half, some cells at bottomWeak positive
W+ (weak+)Faint agglutinates just above cell button, small pelletVery weak positive
NegativeComplete pellet at bottom, gel clearNegative

Visual Representation

|  ====  |  ← 4+ (solid band at top)
|  ----  |
|        |

|  ----  |  ← 3+ (large clumps upper half)
|  ----  |
|        |

|  ----  |  ← 2+ (agglutinates throughout)
|  ----  |
|  ----  |

|        |  ← 1+ (small clumps lower half)
|  ----  |
|  ==    |  ← small pellet

|        |  ← W+ (faint, just above pellet)
|       .|
|  ===   |  ← near-complete pellet

|        |  ← Negative
|        |
|  ====  |  ← complete pellet at bottom

In Context of Your ICT Scenario

Gel GradeTiter Equivalent (approx.)Clinical Significance
W+≤ 1:2 – 1:4Could be passive RhoGAM — repeat & confirm
1+~ 1:4 – 1:8Early alloimmunization — monitor closely
2+~ 1:16 – 1:32Approaching critical level — refer fetal medicine
3+~ 1:32 – 1:64Above critical — urgent fetal surveillance
4+≥ 1:64Severe sensitization — high fetal risk

Important Notes for Gel Card Reading

  • Always read in good lighting against a white background
  • Read within 10 minutes after centrifugation
  • W+ must never be ignored in an Rh-negative pregnant mother
  • A result of 1+ and above = report as positive and refer for titration
  • Hemolysis in the gel = also a positive result (complement activation)

What To Do Based on Gel Grade in Your Patient

Gel ResultImmediate Action
W+Check RhoGAM history — if no recent injection, treat as true positive, do titration
1+Titrate immediately — serial monitoring every 4 weeks
2+ or aboveUrgent referral to fetal medicine + MCA Doppler

Bottom line: Even a W+ on gel card in a G3 Rh-negative mother with Rh+ children should never be dismissed — it warrants full investigation and titration.

Emperipolesis in peripheral smear

Medical Text Search

emperipolesis peripheral blood smear lymphocytes neutrophils

Medical Image Search

emperipolesis peripheral smear microscopy

GradeResponse
GradeResponse

Emperipolesis in Peripheral Smear


Definition

Emperipolesis = the presence of intact, viable hematopoietic cells (lymphocytes, neutrophils, RBCs, platelets) within the cytoplasm of another cell (usually a large histiocyte or monocyte), with the engulfed cell remaining intact and alive inside.
Key distinction from phagocytosis (erythrophagocytosis):
FeatureEmperipolesisPhagocytosis
Engulfed cellIntact, viableDegraded, destroyed
Engulfed cell membranePreservedDisrupted
ProcessPassive — cell moves in voluntarilyActive — cell is ingested & killed
Surrounding vacuolePresent (cells sit in vacuole)Phagolysosome forms

What It Looks Like on Peripheral Smear

  • Large histiocyte/monocyte with abundant pale cytoplasm
  • Intact lymphocytes, neutrophils or RBCs visible inside the cytoplasm
  • Engulfed cells appear normal morphologically — not fragmented
  • Engulfed cells sit in a clear halo/vacuole within the host cell

Image — Emperipolesis (Rosai-Dorfman Disease)

Emperipolesis in Rosai-Dorfman Disease
Large histiocytes with vesicular nuclei and abundant pale cytoplasm containing intact lymphocytes within their cytoplasm — hallmark of emperipolesis in Rosai-Dorfman disease

Causes / Associated Conditions

ConditionNotes
Rosai-Dorfman Disease (RDD)Classic cause — sinus histiocytosis with massive lymphadenopathy
Hemophagocytic Lymphohistiocytosis (HLH)Emperipolesis + erythrophagocytosis both seen
Myeloperoxidase deficiencyNeutrophils inside monocytes
Chronic myeloid leukemia (CML)Occasionally reported
Autoimmune conditionsSLE, rheumatoid arthritis
Viral infectionsEBV, CMV triggered reactive histiocytosis
Post bone marrow transplantReactive phenomenon

Rosai-Dorfman Disease — Key Features

Since RDD is the classic emperipolesis condition:
FeatureDetail
PresentationMassive painless cervical lymphadenopathy
Systemic symptomsFever, night sweats, elevated ESR
Blood pictureLeukocytosis, elevated ESR, hypergammaglobulinemia
ImmunophenotypeS-100 +, CD68 +, CD1a −
PrognosisUsually self-limiting

Emperipolesis vs HLH on Smear

FeatureEmperipolesis (RDD)HLH
Cell engulfedLymphocytes mainlyRBCs, WBCs, platelets
Host cellHistiocyteActivated macrophage
Engulfed cell stateIntactDegraded
ClinicalLymphadenopathyFever, cytopenias, hyperferritinemia
FerritinNormal/mildly raisedMarkedly elevated (>500, often >10,000)

Reporting on Peripheral Smear

When you see emperipolesis, report:
"Large histiocytes noted with intact lymphocytes/neutrophils within their cytoplasm, consistent with emperipolesis. Findings may suggest Rosai-Dorfman disease or reactive histiocytosis. Correlation with clinical findings, lymph node biopsy and immunohistochemistry (S-100, CD68, CD1a) recommended."

Emperipolesis in peripheral smear

Medical Image Search

emperipolesis peripheral blood smear neutrophil inside monocyte

Medical Text Search

emperipolesis peripheral blood smear clinical significance causes

GradeResponse
GradeResponse
It seems you may be asking specifically about emperipolesis seen directly on a peripheral blood smear (not tissue/lymph node). Let me clarify this important distinction:

Emperipolesis on Peripheral Blood Smear — Specific Context


What You Actually See on PBF

On a peripheral blood film, emperipolesis appears as:
  • A monocyte or large mononuclear cell with
  • Intact neutrophil(s), lymphocyte(s), or RBCs sitting inside its cytoplasm
  • The engulfed cell has a clear halo around it
  • The engulfed cell looks morphologically normal — not digested

Most Common Cells Involved on PBF

Host CellEngulfed CellAssociated Condition
MonocyteNeutrophilSystemic inflammation, sepsis
MonocyteLymphocyteViral infections, RDD
Large histiocyteRBCs + WBCs + plateletsHLH
MonocytePlateletsITP, consumptive coagulopathy

Grading on PBF

FindingSignificance
Occasional (1–2 per 100 WBCs)May be incidental / artifact
Frequent (>5 per 100 WBCs)Pathological — investigate further
Prominent + pancytopeniaStrongly suggests HLH

Key Conditions to Consider by PBF Pattern

1. Emperipolesis + Normal CBC

  • Likely reactive — viral infection, post-transfusion
  • May be early Rosai-Dorfman

2. Emperipolesis + Pancytopenia + High Ferritin

  • HLH until proven otherwise
  • Check: Ferritin, triglycerides, fibrinogen, NK cell activity, bone marrow biopsy

3. Emperipolesis + Lymphocytosis + Lymphadenopathy

  • Rosai-Dorfman Disease
  • Biopsy + S100/CD68/CD1a staining needed

4. Emperipolesis + Blast Cells

  • Seen in AML M4/M5 (monocytic leukemia)
  • Monocytic blasts can engulf other cells

Differentials — What Can Mimic It on Smear

MimicHow to Distinguish
PhagocytosisEngulfed cell is degraded/fragmented
Overlapping cellsChange focal plane — overlapping cells separate at different focus levels
Pelger-Huët anomalyNuclear abnormality only, no engulfment
Auer rods in blastsRod-shaped inclusions, not whole cells

Practical Tip at the Bench

When you see a cell inside another cell on PBF:
  1. Focus up and down — overlapping cells will appear at different focal planes
  2. True emperipolesis — engulfed cell stays within the cytoplasm at all focal planes
  3. Check if engulfed cell is intact (emperipolesis) or broken down (phagocytosis/HLH)
  4. Scan multiple fields — count frequency before reporting

Reporting Template for PBF

"Emperipolesis noted — intact [neutrophils/lymphocytes] observed within the cytoplasm of monocytes/histiocytes. Frequency: [occasional/frequent]. Correlation with clinical history, ferritin, LFTs and bone marrow examination recommended to exclude HLH or Rosai-Dorfman disease."
attachment

Interpretation

Gel Card Interpretation — AHG Column


Reading the Image

ColumnLabelFindingGrade
LeftAbId (Antibody Identification)Single compact pellet at bottom, gel clearNegative
RightICTAgglutinates in middle of column + pellet at bottom1+ (Weak Positive)

Interpretation

Left Column — AbId = NEGATIVE

  • Complete cell button at bottom
  • No agglutinates in gel
  • No specific antibody identified in the antibody identification panel
  • Suggests the antibody is not one of the common alloantibodies on the panel cells

Right Column — ICT = 1+ WEAK POSITIVE

  • Agglutinates scattered in lower-mid portion of column
  • Small residual pellet at bottom
  • Confirms antibody is present in maternal serum
  • But too weak to be identified on AbId panel

Clinical Correlation (Linking Back to Your Patient — G3 Rh Negative)

FindingImplication
ICT 1+ positiveAntibody present in maternal circulation
AbId negativeAntibody is below detection threshold of panel OR is a low-frequency antigen antibody not on standard panel
Combined resultLikely very early / low titer alloimmunization OR residual passive anti-D from RhoGAM

Possible Explanations for This Pattern

  1. Passive Anti-D from recent RhoGAM injection
    • Titer too low to react with all panel cells
    • ICT weakly positive, AbId negative = classic RhoGAM pattern
  2. True early alloimmunization
    • Anti-D forming but titer very low
    • Not yet strong enough to identify on panel
  3. Antibody to low-frequency antigen
    • Not represented on standard panel cells
    • Rare but possible

Next Steps

ActionReason
Check RhoGAM injection historyRule out passive anti-D
Repeat ICT in 2–4 weeksSee if titer rising (true alloimmunization)
Perform antibody titrationQuantify antibody level
Enzyme technique (papain/ficin)Enhance weak antibody reactivity for better identification
Extended panel if enzyme positiveIdentify specific antibody

Bottom Line

ICT 1+ with negative AbId = antibody is present but weak. In a G3 Rh-negative mother, this must be taken seriously — do not dismiss. Differentiate passive RhoGAM from true alloimmunization by clinical history and serial testing.
This is a shared conversation. Sign in to Orris to start your own chat.